Europe — EMA

Olanzapine Accord

Olanzapine, the active ingredient in Olanzapine Accord, is an atypical antipsychotic presented as a tablet for oral use. It is used to manage symptoms of schizophrenia and bipolar disorder in adults.

Olanzapine

Request sourcing

Pack/s

What is Olanzapine?

Olanzapine, the active ingredient in Olanzapine Accord, is an atypical antipsychotic presented as a tablet for oral use. It is used to manage symptoms of schizophrenia and bipolar disorder in adults. GNH USA supplies Olanzapine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olanzapine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olanzapine used for?

Olanzapine Accord is an atypical antipsychotic that acts on dopamine and serotonin pathways to treat serious mental health conditions.

- Schizophrenia: Reduces hallucinations, delusions and thought disorder. - Bipolar I disorder: Controls manic episodes and stabilises mood. - Schizoaffective disorder: Allevi recognised -

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →